Search

Adam C. Milligan

Examiner (ID: 858, Phone: (571)270-7674 , Office: P/1612 )

Most Active Art Unit
1612
Art Unit(s)
1623, 1612
Total Applications
585
Issued Applications
143
Pending Applications
10
Abandoned Applications
437

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 15796887 [patent_doc_number] => 20200121586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-23 [patent_title] => COMPOSITION COMPRISING CHARCOAL AND AN EXTRACT OR SUBSTANCE OF ASTROCARYUM MURUMURU [patent_app_type] => utility [patent_app_number] => 16/656674 [patent_app_country] => US [patent_app_date] => 2019-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4351 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16656674 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/656674
COMPOSITION COMPRISING CHARCOAL AND AN EXTRACT OR SUBSTANCE OF ASTROCARYUM MURUMURU Oct 17, 2019 Abandoned
Array ( [id] => 15450953 [patent_doc_number] => 20200038300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-06 [patent_title] => ORAL CARE FORMULATION SYSTEM PROVIDING AMORPHOUS CALCIUM PHOSPHATE [patent_app_type] => utility [patent_app_number] => 16/599827 [patent_app_country] => US [patent_app_date] => 2019-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6599 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16599827 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/599827
ORAL CARE FORMULATION SYSTEM PROVIDING AMORPHOUS CALCIUM PHOSPHATE Oct 10, 2019 Abandoned
Array ( [id] => 19535600 [patent_doc_number] => 12128133 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-10-29 [patent_title] => Ingestible device with expandable enclosure [patent_app_type] => utility [patent_app_number] => 16/579112 [patent_app_country] => US [patent_app_date] => 2019-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 48 [patent_no_of_words] => 20390 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 320 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16579112 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/579112
Ingestible device with expandable enclosure Sep 22, 2019 Issued
Array ( [id] => 15320755 [patent_doc_number] => 20200000707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-02 [patent_title] => Oral Therapeutic Compound Delivery System [patent_app_type] => utility [patent_app_number] => 16/570184 [patent_app_country] => US [patent_app_date] => 2019-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13939 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16570184 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/570184
Oral Therapeutic Compound Delivery System Sep 12, 2019 Abandoned
Array ( [id] => 15320857 [patent_doc_number] => 20200000758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-02 [patent_title] => Oral Dosage Forms Of Methyl Hydrogen Fumarate And Prodrugs Thereof [patent_app_type] => utility [patent_app_number] => 16/566696 [patent_app_country] => US [patent_app_date] => 2019-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24939 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16566696 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/566696
Oral Dosage Forms Of Methyl Hydrogen Fumarate And Prodrugs Thereof Sep 9, 2019 Abandoned
Array ( [id] => 18301124 [patent_doc_number] => 11623010 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-04-11 [patent_title] => Pharmaceutical carrier in the preparation of an anti-diabetic pharmaceutical composition and methods for treatment [patent_app_type] => utility [patent_app_number] => 16/553056 [patent_app_country] => US [patent_app_date] => 2019-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4099 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16553056 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/553056
Pharmaceutical carrier in the preparation of an anti-diabetic pharmaceutical composition and methods for treatment Aug 26, 2019 Issued
Array ( [id] => 16539280 [patent_doc_number] => 20200405693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-31 [patent_title] => REDUCED DOSE METAXALONE FORMULATIONS [patent_app_type] => utility [patent_app_number] => 16/524952 [patent_app_country] => US [patent_app_date] => 2019-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4980 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16524952 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/524952
REDUCED DOSE METAXALONE FORMULATIONS Jul 28, 2019 Abandoned
Array ( [id] => 15264461 [patent_doc_number] => 20190380964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-19 [patent_title] => METHODS AND COMPOSITIONS FOR MAKING AND USING NANOTHERAPEUTIC DRUG DELIVERY VEHICLES [patent_app_type] => utility [patent_app_number] => 16/444360 [patent_app_country] => US [patent_app_date] => 2019-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16507 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16444360 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/444360
METHODS AND COMPOSITIONS FOR MAKING AND USING NANOTHERAPEUTIC DRUG DELIVERY VEHICLES Jun 17, 2019 Abandoned
Array ( [id] => 17088560 [patent_doc_number] => 11116728 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-09-14 [patent_title] => Multiparticulates of spray-coated drug and polymer on a meltable core [patent_app_type] => utility [patent_app_number] => 16/440907 [patent_app_country] => US [patent_app_date] => 2019-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 5 [patent_no_of_words] => 18090 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16440907 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/440907
Multiparticulates of spray-coated drug and polymer on a meltable core Jun 12, 2019 Issued
Array ( [id] => 17109931 [patent_doc_number] => 20210290528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-23 [patent_title] => Compositions Comprising Guaifenesin and Eriodictyol [patent_app_type] => utility [patent_app_number] => 17/267703 [patent_app_country] => US [patent_app_date] => 2019-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5978 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17267703 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/267703
Compositions Comprising Guaifenesin and Eriodictyol Apr 29, 2019 Abandoned
Array ( [id] => 17241838 [patent_doc_number] => 20210361581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-25 [patent_title] => ADDITIVE FOR A POWDER MATERIAL INTENDED FOR COMPACTION INTO SHAPED BODIES [patent_app_type] => utility [patent_app_number] => 17/278674 [patent_app_country] => US [patent_app_date] => 2019-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5632 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17278674 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/278674
ADDITIVE FOR A POWDER MATERIAL INTENDED FOR COMPACTION INTO SHAPED BODIES Apr 29, 2019 Abandoned
Array ( [id] => 16397295 [patent_doc_number] => 20200338153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-29 [patent_title] => ANAEROBIC ANTIOXIDANT COMPOSITION [patent_app_type] => utility [patent_app_number] => 16/398210 [patent_app_country] => US [patent_app_date] => 2019-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11712 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16398210 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/398210
ANAEROBIC ANTIOXIDANT COMPOSITION Apr 28, 2019 Abandoned
Array ( [id] => 16868357 [patent_doc_number] => 20210161824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-03 [patent_title] => ORALLY DISINTEGRATING TABLETS COMPRISING GLYCOPYRROLATE AND METHODS FOR INCREASING BIOAVAILABILITY [patent_app_type] => utility [patent_app_number] => 17/049476 [patent_app_country] => US [patent_app_date] => 2019-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6473 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17049476 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/049476
ORALLY DISINTEGRATING TABLETS COMPRISING GLYCOPYRROLATE AND METHODS FOR INCREASING BIOAVAILABILITY Mar 11, 2019 Abandoned
Array ( [id] => 16709572 [patent_doc_number] => 20210076719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-18 [patent_title] => COMPOSITION COMPRISING GLUCOSYLATED TERPENE GLYCOSIDES, TERPENE GLYCOSIDES AND CYCLODEXTRINE [patent_app_type] => utility [patent_app_number] => 16/954329 [patent_app_country] => US [patent_app_date] => 2019-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2961 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16954329 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/954329
COMPOSITION COMPRISING GLUCOSYLATED TERPENE GLYCOSIDES, TERPENE GLYCOSIDES AND CYCLODEXTRINE Feb 24, 2019 Abandoned
Array ( [id] => 16504759 [patent_doc_number] => 20200384015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-10 [patent_title] => MAGNESIUM/LITHIUM PREPARATIONS FOR NEUROPROTECTION AND NEUROTROPHIC BENEFITS [patent_app_type] => utility [patent_app_number] => 16/471519 [patent_app_country] => US [patent_app_date] => 2019-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4038 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16471519 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/471519
Magnesium/lithium preparations for neuroprotection and neurotrophic benefits Feb 17, 2019 Issued
Array ( [id] => 14435311 [patent_doc_number] => 20190175527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-13 [patent_title] => ORGANIC COMPOUNDS [patent_app_type] => utility [patent_app_number] => 16/274357 [patent_app_country] => US [patent_app_date] => 2019-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5960 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16274357 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/274357
ORGANIC COMPOUNDS Feb 12, 2019 Abandoned
Array ( [id] => 18027739 [patent_doc_number] => 11510898 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-29 [patent_title] => Limited release lingual thioctic acid delivery systems [patent_app_type] => utility [patent_app_number] => 16/261444 [patent_app_country] => US [patent_app_date] => 2019-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16340 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 192 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16261444 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/261444
Limited release lingual thioctic acid delivery systems Jan 28, 2019 Issued
Array ( [id] => 14306099 [patent_doc_number] => 20190142753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-16 [patent_title] => METHOD OF PREPARING PHARMACEUTICAL MICROSPHERE [patent_app_type] => utility [patent_app_number] => 16/247605 [patent_app_country] => US [patent_app_date] => 2019-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4830 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16247605 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/247605
METHOD OF PREPARING PHARMACEUTICAL MICROSPHERE Jan 14, 2019 Abandoned
16/240642 INTRANASAL DELIVERY OF LEVODOPA POWDER BY PRECISION OLFACTORY DEVICE Jan 3, 2019
Array ( [id] => 14273279 [patent_doc_number] => 20190133924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-09 [patent_title] => Alcohol-Resistant Formulations [patent_app_type] => utility [patent_app_number] => 16/239222 [patent_app_country] => US [patent_app_date] => 2019-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11772 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 261 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16239222 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/239222
Alcohol-Resistant Formulations Jan 2, 2019 Abandoned
Menu